These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6108233)

  • 1. [Effect of the antihistamine preparation, phencarol, on the central nervous system].
    Kaminka ME; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phencarol--an antihistaminic preparation from the quinuclidylcarbinol group].
    Kaminka WE
    Farmakol Toksikol; 1977; 40(2):158-62. PubMed ID: 15861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the new Soviet antihistamine and antiserotonin preparation bikarfen on the central nervous system].
    Kaminka ME; Kuksgauz NE; Andreeva NI
    Farmakol Toksikol; 1990; 53(4):21-3. PubMed ID: 1977614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of the new Soviet, tritium-labelled, antihistamine preparation, phencarol].
    Kaminka ME; Spryshkova RA; Golovanova IV
    Farmakol Toksikol; 1978; 41(3):279-83. PubMed ID: 26596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of new antihistaminic preparations on the body's immunologic reactivity].
    Mashkovskiĭ MD; Veksler IG; Kaminka ME; Iakimenko VA
    Biull Eksp Biol Med; 1981 Mar; 91(3):340-2. PubMed ID: 6113860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the antihistamine preparation, fencarol, and other quinuclidyldiarylcarbinols on tissue aminoxidase activity].
    Baumanis EA; Gorkin VZ; Kalninia IE; Kaminka ME; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(1):36-41. PubMed ID: 6103819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918).
    Fink M; Irwin P
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):35-44. PubMed ID: 33398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rat placental barrier permeability for the new antihistaminic preparation, fenkarol].
    Golovanova IV; Spryshkova RA; Golovanova EA; Chivireva AM
    Farmakol Toksikol; 1978; 41(1):65-9. PubMed ID: 23959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antihistaminic preparations on gastric secretion in rats].
    Kaminka ME; Tupikina SM; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1983 May; 95(5):44-6. PubMed ID: 6133570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of antihistaminics on bradykinin action].
    Shvarts GIa
    Biull Eksp Biol Med; 1979 Oct; 88(10):419-21. PubMed ID: 40631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the antiedema activity of antihistamine preparations compared to the dynamics of their concentration in the blood serum].
    Kholodov LE; Kaverina LP; Dorokhov VV
    Farmakol Toksikol; 1985; 48(1):43-5. PubMed ID: 2858404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic properties of N-oxides of certain antihistaminic drugs.
    Gieldanowski J; Prastowski W
    Arch Immunol Ther Exp (Warsz); 1965; 13(6):657-65. PubMed ID: 4379532
    [No Abstract]   [Full Text] [Related]  

  • 15. [Derivative of 4,9-dihydrothieno(2,3-b)benzo(e)thiepine--a new type of effective antihistaminic].
    Metys J; Metysová J
    Acta Biol Med Ger; 1965; 15(6):871-3. PubMed ID: 4160911
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-allergic properties of dimebon, fencarol and ketotifen in sensitization by common ragweed pollen].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Il'iuchenok TI; Pasechnikov FG; Khanferian RA
    Farmakol Toksikol; 1984; 47(3):75-8. PubMed ID: 6145622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
    Ishii K; Yakuo I; Nakagawa H; Nakamura H
    Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological studies on oxatomide. (5). Effect on the central and peripheral nervous systems].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):245-66. PubMed ID: 6134657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.